~/ARTIFICIAL I/eli-lilly-ceo-pushes-back-on-anthropic-ceo-s-medical-ai-claims

Eli Lilly CEO Pushes Back on Anthropic CEO's Medical AI Claims

Eli Lilly's CEO has publicly pushed back against ambitious claims made by Anthropic CEO Dario Amodei regarding how quickly artificial intelligence will revolutionize medical and drug discovery. The clash highlights a growing tension between AI industry optimism and the realities of pharmaceutical development. This debate underscores the gap between software-based AI breakthroughs and the slow, physical limitations of medical research. It serves as a reminder to manage expectations regarding AI's timeline in highly regulated, physical science domains. Critics point out that drug development is constrained by slow physical experimental loops and regulatory barriers rather than computing power. Unlike software coding, where AI can iterate rapidly, biological testing requires physical time and clinical trials.

## KEYWORDS

#Artificial Intelligence#Healthcare#Drug Discovery#AI Hype

$ subscribe --daily